Therefore, exploring the mechanism of EMT and mitochondrial-dependent apoptotic cell death, blocking TGF-β production, blocking signal transduction, and/or inhibiting oxidative stress could provide promising therapeutic strategies to control and even reverse liver fibrosis. The gene discussed is TGFB1; the disease is Hepatic fibrosis.